Dentsply Sirona (XRAY)
Dentsply Sirona on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as dental equipment & supplies.
25.5M
Short interest
settlement 2026-09-30
4.5
Days to cover
-2.4 days vs prior
56.2%
Short share of volume
2026-10-23
3,388
Fails to deliver
settlement 2026-09-21
Thu 5 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in XRAY is 25,531,560 shares, up 3,445,729 shares over the last month. Over the last 48 readings it ranged from 7,176,058 shares (31 July 2025) to 29,935,825 shares (15 July 2026). At the reported average volume of 5.7M shares a day that is 4.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/xray" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 25,531,560 | +3.8% | 5,723,132 | 4.46 |
| 2026-09-15 | 24,588,198 | +11.3% | 3,556,470 | 6.91 |
| 2026-08-31 | 22,085,831 | +12.2% | 3,432,449 | 6.43 |
| 2026-08-14 | 19,679,573 | -16.6% | 5,178,647 | 3.80 |
| 2026-07-31 | 23,604,124 | -21.1% | 4,970,100 | 4.75 |
| 2026-07-15 | 29,935,825 | +2.5% | 5,029,513 | 5.95 |
| 2026-06-30 | 29,218,238 | +18.2% | 7,597,373 | 3.85 |
| 2026-06-15 | 24,724,990 | +13.0% | 4,335,430 | 5.70 |
| 2026-05-29 | 21,876,433 | -7.7% | 7,017,778 | 3.12 |
| 2026-05-15 | 23,696,061 | +10.5% | 6,153,217 | 3.85 |
| 2026-04-30 | 21,441,842 | +5.6% | 3,335,152 | 6.43 |
| 2026-04-15 | 20,313,075 | -0.9% | 2,850,791 | 7.13 |
| 2026-03-31 | 20,507,698 | +20.1% | 4,379,656 | 4.68 |
| 2026-03-13 | 17,078,124 | +31.7% | 5,006,471 | 3.41 |
| 2026-02-27 | 12,965,700 | -11.8% | 5,811,915 | 2.23 |
| 2026-02-13 | 14,703,880 | +1.3% | 4,957,455 | 2.97 |
| 2026-01-30 | 14,514,598 | -1.4% | 3,858,026 | 3.76 |
| 2026-01-15 | 14,718,584 | -1.7% | 4,361,586 | 3.37 |
| 2025-12-31 | 14,976,914 | +22.8% | 3,429,736 | 4.37 |
| 2025-12-15 | 12,198,249 | -14.1% | 3,371,923 | 3.62 |
| 2025-11-28 | 14,200,459 | +5.5% | 3,833,081 | 3.70 |
| 2025-11-14 | 13,457,231 | +28.8% | 4,725,201 | 2.85 |
| 2025-10-31 | 10,444,969 | +16.6% | 2,662,216 | 3.92 |
| 2025-10-15 | 8,961,408 | -6.0% | 3,527,154 | 2.54 |
| 2025-09-30 | 9,536,789 | +7.6% | 3,373,471 | 2.83 |
| 2025-09-15 | 8,862,044 | +16.0% | 2,772,281 | 3.20 |
| 2025-08-29 | 7,641,849 | -3.0% | 2,700,666 | 2.83 |
| 2025-08-15 | 7,878,354 | +9.8% | 4,963,734 | 1.59 |
| 2025-07-31 | 7,176,058 | -8.5% | 3,468,694 | 2.07 |
| 2025-07-15 | 7,839,526 | -0.6% | 2,014,312 | 3.89 |
| 2025-06-30 | 7,888,793 | -5.9% | 2,455,108 | 3.21 |
| 2025-06-13 | 8,380,363 | -6.2% | 1,945,533 | 4.31 |
| 2025-05-30 | 8,935,365 | -6.1% | 2,563,883 | 3.49 |
| 2025-05-15 | 9,516,419 | +15.3% | 3,807,711 | 2.50 |
| 2025-04-30 | 8,251,828 | -24.1% | 2,709,575 | 3.05 |
| 2025-04-15 | 10,869,710 | +0.8% | 3,610,877 | 3.01 |
| 2025-03-31 | 10,781,052 | +2.0% | 3,378,381 | 3.19 |
| 2025-03-14 | 10,572,647 | +31.1% | 3,236,991 | 3.27 |
| 2025-02-28 | 8,062,722 | +0.9% | 3,058,147 | 2.64 |
| 2025-02-14 | 7,989,732 | -1.3% | 2,137,043 | 3.74 |
| 2025-01-31 | 8,093,325 | -6.4% | 2,195,401 | 3.69 |
| 2025-01-15 | 8,644,488 | -12.2% | 2,663,260 | 3.25 |
| 2024-12-31 | 9,841,255 | +13.0% | 3,143,918 | 3.13 |
| 2024-12-13 | 8,706,889 | +2.1% | 2,559,367 | 3.40 |
| 2024-11-29 | 8,525,562 | -13.8% | 2,501,680 | 3.41 |
| 2024-11-15 | 9,891,811 | -28.1% | 6,549,334 | 1.51 |
| 2024-10-31 | 13,766,976 | -15.8% | 2,420,610 | 5.69 |
| 2024-10-15 | 16,350,203 | -14.7% | 1,968,772 | 8.30 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of XRAY volume is 56.2%, up 13.3 points over the last five sessions. Over the last 30 readings it ranged from 32.4% (20 October 2026) to 70.1% (16 September 2026). The latest reading is in line with the 30-session average of 55.3%, on 1.4M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 788K | 1.4M | 56.2% | 4,234 |
| 2026-10-22 | 865K | 1.7M | 51.5% | 70 |
| 2026-10-21 | 1.2M | 1.8M | 66.6% | 0 |
| 2026-10-20 | 880K | 2.7M | 32.4% | 15 |
| 2026-10-19 | 936K | 1.8M | 52.8% | 1,658 |
| 2026-10-16 | 818K | 1.9M | 42.9% | 1,000 |
| 2026-10-15 | 1.0M | 1.8M | 57.1% | 419 |
| 2026-10-14 | 959K | 1.6M | 60.8% | 753 |
| 2026-10-13 | 959K | 1.6M | 59.1% | 710 |
| 2026-10-12 | 1.3M | 2.1M | 63.6% | 1,334 |
| 2026-10-09 | 959K | 1.6M | 61.3% | 6 |
| 2026-10-08 | 968K | 2.1M | 45.9% | 1,400 |
| 2026-10-07 | 1.1M | 1.9M | 60.2% | 32 |
| 2026-10-06 | 1.1M | 1.9M | 57.7% | 29 |
| 2026-10-05 | 1.3M | 2.4M | 52.3% | 8 |
| 2026-10-02 | 1.0M | 2.9M | 36.1% | 2,764 |
| 2026-10-01 | 1.4M | 2.7M | 51.1% | 3,617 |
| 2026-09-30 | 1.2M | 2.3M | 53.9% | 2,921 |
| 2026-09-29 | 961K | 1.9M | 49.7% | 5 |
| 2026-09-28 | 1.1M | 2.8M | 38.0% | 0 |
| 2026-09-25 | 1.0M | 1.9M | 55.1% | 5,506 |
| 2026-09-24 | 839K | 1.5M | 56.3% | 6 |
| 2026-09-23 | 813K | 1.2M | 66.6% | 0 |
| 2026-09-22 | 972K | 1.7M | 56.1% | 0 |
| 2026-09-21 | 1.3M | 2.5M | 53.1% | 78 |
| 2026-09-18 | 1.4M | 2.6M | 56.3% | 68 |
| 2026-09-17 | 2.3M | 3.6M | 62.5% | 0 |
| 2026-09-16 | 1.6M | 2.3M | 70.1% | 4,305 |
| 2026-09-15 | 1.2M | 1.8M | 67.5% | 747 |
| 2026-09-14 | 735K | 1.1M | 65.1% | 100 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 21 September 2026, the fails-to-deliver balance in XRAY is 3,388 shares, up 3,104 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (21 July 2026) to 258,219 shares (16 March 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-21 | 3,388 | $9.54 | $32K |
| 2026-09-08 | 284 | $11.38 | $3K |
| 2026-09-03 | 1,560 | $11.29 | $18K |
| 2026-08-14 | 657 | $11.58 | $8K |
| 2026-08-11 | 432 | $11.66 | $5K |
| 2026-08-07 | 1 | $13.17 | $13 |
| 2026-07-31 | 301 | $13.74 | $4K |
| 2026-07-23 | 2,331 | $13.27 | $31K |
| 2026-07-21 | 1 | $13.46 | $13 |
| 2026-07-20 | 428 | $14.05 | $6K |
| 2026-07-17 | 28 | $13.85 | $388 |
| 2026-07-15 | 19,374 | $12.70 | $246K |
| 2026-07-10 | 1,183 | $11.89 | $14K |
| 2026-07-09 | 1,583 | $11.78 | $19K |
| 2026-07-07 | 290 | $12.32 | $4K |
| 2026-07-02 | 1,715 | $11.09 | $19K |
| 2026-07-01 | 11,532 | $10.61 | $122K |
| 2026-06-26 | 3,072 | $10.78 | $33K |
| 2026-06-22 | 177 | $10.33 | $2K |
| 2026-06-18 | 8,497 | $10.03 | $85K |
| 2026-06-15 | 1,910 | $10.09 | $19K |
| 2026-05-21 | 84,572 | $9.84 | $832K |
| 2026-05-13 | 51,820 | $11.00 | $570K |
| 2026-04-24 | 83 | $11.90 | $988 |
| 2026-04-20 | 15 | $12.51 | $188 |
| 2026-04-15 | 7,673 | $12.22 | $94K |
| 2026-04-02 | 283 | $11.66 | $3K |
| 2026-03-25 | 77,211 | $11.47 | $886K |
| 2026-03-23 | 120 | $10.95 | $1K |
| 2026-03-16 | 258,219 | $11.54 | $3.0M |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for XRAY in the last 90 days. The most recent filings are listed below. Latest filing: Fortson John C. (EVP & CFO) on 2026-08-10.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Fortson John C. | EVP & CFO | Grant | 24K | $0.00 | $0 | 24K |
| 2026-08-07 | Frohning Andrea L. | SVP, CHRO | Tax withholding | 802 | $12.12 | $10K | 63K |
| 2026-06-15 | Gladden Brian T | Director | Buy | 10K | $10.02 | $100K | 62K |
| 2026-06-15 | HOSEIN CLYDE | Director | Buy | 7K | $9.99 | $65K | 71K |
| 2026-06-12 | MAZELSKY JONATHAN JAY | Director | Grant | 10K | $10.14 | $101K | 62K |
| 2026-06-12 | MCKEON BRIAN P | Director | Buy | 10K | $10.12 | $101K | 10K |
| 2026-06-12 | MAZELSKY JONATHAN JAY | Director | Buy | 10K | $10.14 | $101K | 62K |
| 2026-06-11 | HOLDEN BETSY D | Director | Buy | 10K | $9.88 | $100K | 88K |
| 2026-06-11 | Barber Michael J | Director | Buy | 15K | $9.88 | $150K | 56K |
| 2026-06-03 | LUCIER GREGORY T | Director | Gift | 38K | $0.00 | $0 | 63K |
| 2026-06-03 | LUCIER GREGORY T | Director | Gift | 38K | $0.00 | $0 | 0 |
| 2026-06-03 | LUCIER GREGORY T | Director | Grant | 38K | $0.00 | $0 | 38K |
| 2026-06-03 | Zurbay Donald | Director | Grant | 23K | $0.00 | $0 | 30K |
| 2026-06-03 | Vergis Janet S. | Director | Grant | 23K | $0.00 | $0 | 67K |
| 2026-06-03 | VARON LESLIE F | Director | Grant | 23K | $0.00 | $0 | 80K |
| 2026-06-03 | MCKEON BRIAN P | Director | Grant | 29K | $0.00 | $0 | 29K |
| 2026-06-03 | MAZELSKY JONATHAN JAY | Director | Grant | 23K | $0.00 | $0 | 52K |
| 2026-06-03 | HOSEIN CLYDE | Director | Grant | 23K | $0.00 | $0 | 64K |
| 2026-06-03 | HOLDEN BETSY D | Director | Grant | 23K | $0.00 | $0 | 77K |
| 2026-06-03 | Gladden Brian T | Director | Grant | 23K | $0.00 | $0 | 52K |
| 2026-06-03 | Forbes James D | Director | Grant | 29K | $0.00 | $0 | 39K |
| 2026-06-03 | Barber Michael J | Director | Grant | 23K | $0.00 | $0 | 41K |
| 2026-05-22 | Scavilla Daniel T | President, CEO & Member of BOD | Tax withholding | 4K | $10.21 | $42K | 158K |
| 2026-03-09 | LUCIER GREGORY T | Director | Buy | 15K | $12.45 | $187K | 65K |
| 2026-03-09 | Forbes James D | Director | Buy | 5K | $12.48 | $62K | 10K |
| 2026-03-04 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Tax withholding | 1K | $13.44 | $14K | 117K |
| 2026-03-04 | Frohning Andrea L. | SVP, CHRO | Tax withholding | 690 | $13.44 | $9K | 37K |
| 2026-03-04 | Czerney Kevin | VP, Chief Accounting Officer | Tax withholding | 328 | $13.44 | $4K | 28K |
| 2026-03-04 | Frohning Andrea L. | SVP, CHRO | Grant | 27K | $0.00 | $0 | 64K |
| 2026-03-04 | Denti Aldo Mariano Roberto | EVP, Chief Commercial Officer | Grant | 60K | $0.00 | $0 | 60K |
| 2026-03-04 | Scavilla Daniel T | President, CEO & Member of BOD | Grant | 145K | $0.00 | $0 | 162K |
| 2026-03-04 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Grant | 45K | $0.00 | $0 | 162K |
| 2026-03-04 | Czerney Kevin | VP, Chief Accounting Officer | Grant | 14K | $0.00 | $0 | 41K |
| 2026-03-03 | LUCIER GREGORY T | Director | Buy | 22K | $14.03 | $315K | 50K |
| 2026-03-03 | Forbes James D | Director | Buy | 5K | $13.47 | $67K | 5K |
| 2026-03-03 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Tax withholding | 4K | $13.30 | $60K | 118K |
| 2026-03-03 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Tax withholding | 3K | $13.30 | $43K | 123K |
| 2026-03-03 | Frohning Andrea L. | SVP, CHRO | Tax withholding | 2K | $13.30 | $26K | 38K |
| 2026-03-03 | Frohning Andrea L. | SVP, CHRO | Tax withholding | 3K | $13.30 | $40K | 40K |
| 2026-03-03 | Czerney Kevin | VP, Chief Accounting Officer | Tax withholding | 1K | $13.30 | $16K | 28K |
| 2026-03-03 | Czerney Kevin | VP, Chief Accounting Officer | Tax withholding | 527 | $13.30 | $7K | 29K |
| 2026-03-02 | LUCIER GREGORY T | Director | Buy | 28K | $14.24 | $393K | 28K |
| 2026-03-02 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Grant | 10K | $0.00 | $0 | 126K |
| 2026-03-02 | Frohning Andrea L. | SVP, CHRO | Grant | 9K | $0.00 | $0 | 43K |
| 2026-03-02 | Czerney Kevin | VP, Chief Accounting Officer | Grant | 1K | $0.00 | $0 | 30K |
| 2026-02-24 | Scavilla Daniel T | President, CEO & Member of BOD | Tax withholding | 1K | $13.14 | $16K | 17K |
| 2026-01-26 | Zurbay Donald | Director | Grant | 7K | $0.00 | $0 | 7K |
| 2026-01-09 | Barber Michael J | Director | Grant | 246 | $0.00 | $0 | 18K |
| 2026-01-09 | Czerney Kevin | VP, Chief Accounting Officer | Grant | 263 | $0.00 | $0 | 28K |
| 2026-01-09 | Deese Willie A | Director | Grant | 202 | $0.00 | $0 | 58K |
| 2026-01-09 | Frohning Andrea L. | SVP, CHRO | Grant | 392 | $0.00 | $0 | 34K |
| 2026-01-09 | Gladden Brian T | Director | Grant | 315 | $0.00 | $0 | 29K |
| 2026-01-09 | HOLDEN BETSY D | Director | Grant | 711 | $0.00 | $0 | 55K |
| 2026-01-09 | HOSEIN CLYDE | Director | Grant | 355 | $0.00 | $0 | 41K |
| 2026-01-09 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Grant | 642 | $0.00 | $0 | 116K |
| 2026-01-09 | LUCIER GREGORY T | Director | Grant | 341 | $0.00 | $0 | 25K |
| 2026-01-09 | MAZELSKY JONATHAN JAY | Director | Grant | 395 | $0.00 | $0 | 29K |
| 2026-01-09 | Scavilla Daniel T | President, CEO & Member of BOD | Grant | 246 | $0.00 | $0 | 18K |
| 2026-01-09 | VARON LESLIE F | Director | Grant | 198 | $0.00 | $0 | 58K |
| 2026-01-09 | Vergis Janet S. | Director | Grant | 201 | $0.00 | $0 | 45K |
| 2026-01-09 | Vergis Janet S. | Director | Grant | 201 | $0.00 | $0 | 45K |
| 2026-01-09 | VARON LESLIE F | Director | Grant | 198 | $0.00 | $0 | 58K |
| 2026-01-09 | Scavilla Daniel T | President, CEO & Member of BOD | Grant | 246 | $0.00 | $0 | 18K |
| 2026-01-09 | MAZELSKY JONATHAN JAY | Director | Grant | 395 | $0.00 | $0 | 29K |
| 2026-01-09 | LUCIER GREGORY T | Director | Grant | 341 | $0.00 | $0 | 25K |
| 2026-01-09 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Grant | 642 | $0.00 | $0 | 116K |
| 2026-01-09 | HOSEIN CLYDE | Director | Grant | 355 | $0.00 | $0 | 41K |
| 2026-01-09 | HOLDEN BETSY D | Director | Grant | 711 | $0.00 | $0 | 55K |
| 2026-01-09 | Gladden Brian T | Director | Grant | 315 | $0.00 | $0 | 29K |
| 2026-01-09 | Frohning Andrea L. | SVP, CHRO | Grant | 392 | $0.00 | $0 | 34K |
| 2026-01-09 | Deese Willie A | Director | Grant | 202 | $0.00 | $0 | 58K |
| 2026-01-09 | Czerney Kevin | VP, Chief Accounting Officer | Grant | 263 | $0.00 | $0 | 28K |
| 2026-01-09 | Barber Michael J | Director | Grant | 246 | $0.00 | $0 | 18K |
| 2025-12-08 | LUCIER GREGORY T | Director | Sell | 82K | $11.14 | $916K | 0 |
| 2025-11-28 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Tax withholding | 9K | $11.34 | $99K | 115K |
| 2025-11-28 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Tax withholding | 293 | $11.34 | $3K | 124K |
| 2025-11-24 | VARON LESLIE F | Director | Buy | 9K | $10.71 | $100K | 57K |
| 2025-10-10 | Barber Michael J | Director | Grant | 224 | $0.00 | $0 | 18K |
| 2025-10-10 | Czerney Kevin | VP, Chief Accounting Officer | Grant | 234 | $0.00 | $0 | 27K |
| 2025-10-10 | Deese Willie A | Director | Grant | 179 | $0.00 | $0 | 58K |
| 2025-10-10 | Frohning Andrea L. | SVP, CHRO | Grant | 357 | $0.00 | $0 | 34K |
| 2025-10-10 | GARTH MATTHEW E | EVP & CFO | Grant | 556 | $0.00 | $0 | 44K |
| 2025-10-10 | Gladden Brian T | Director | Grant | 286 | $0.00 | $0 | 29K |
| 2025-10-10 | HOLDEN BETSY D | Director | Grant | 647 | $0.00 | $0 | 54K |
| 2025-10-10 | HOSEIN CLYDE | Director | Grant | 286 | $0.00 | $0 | 41K |
| 2025-10-10 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Grant | 972 | $0.00 | $0 | 124K |
| 2025-10-10 | LUCIER GREGORY T | Director | Grant | 310 | $0.00 | $0 | 24K |
| 2025-10-10 | MAZELSKY JONATHAN JAY | Director | Grant | 360 | $0.00 | $0 | 28K |
| 2025-10-10 | ROSENZWEIG RICHARD C | EVP, Corp Dev, GC & Secretary | Grant | 766 | $0.00 | $0 | 85K |
| 2025-10-10 | Scavilla Daniel T | President, CEO & Member of BOD | Grant | 224 | $0.00 | $0 | 18K |
| 2025-10-10 | VARON LESLIE F | Director | Grant | 179 | $0.00 | $0 | 48K |
| 2025-10-10 | Vergis Janet S. | Director | Grant | 179 | $0.00 | $0 | 44K |
| 2025-10-10 | Vergis Janet S. | Director | Grant | 179 | $0.00 | $0 | 44K |
| 2025-10-10 | VARON LESLIE F | Director | Grant | 179 | $0.00 | $0 | 48K |
| 2025-10-10 | Scavilla Daniel T | President, CEO & Member of BOD | Grant | 224 | $0.00 | $0 | 18K |
| 2025-10-10 | ROSENZWEIG RICHARD C | EVP, Corp Dev, GC & Secretary | Grant | 766 | $0.00 | $0 | 85K |
| 2025-10-10 | MAZELSKY JONATHAN JAY | Director | Grant | 360 | $0.00 | $0 | 28K |
| 2025-10-10 | LUCIER GREGORY T | Director | Grant | 310 | $0.00 | $0 | 24K |
| 2025-10-10 | Johnson Robert Anthony | SVP, Chief Supply Chain Office | Grant | 972 | $0.00 | $0 | 124K |
| 2025-10-10 | HOSEIN CLYDE | Director | Grant | 286 | $0.00 | $0 | 41K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for XRAY worth $912K at the prices reported; 0 in the last 90 days worth $0. Latest: LUCIER GREGORY T filed on 2025-12-11 to sell 82,200 shares ($912K) from 2025-12-08.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2025-12-11 | LUCIER GREGORY TDIRECTOR | 82K | $912K | 0.041% | 2025-12-08 | Tourmaline Partners, LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON5 holders report 5% or more of XRAY in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 12.6% of the class (25,295,015 shares), filed 2026-07-08 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 1 | Southpoint Master Fund, LPpartnership | 7.0M | 3.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Southpoint Capital Advisors LPpartnership | 7.0M | 3.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Southpoint Capital Advisors LLCother entity | 7.0M | 3.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Southpoint GP, LPpartnership | 7.0M | 3.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Southpoint GP, LLCother entity | 7.0M | 3.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | John S. Clark IIindividual | 7.0M | 3.5% | 2026-06-30 |
| 2026-08-13 | 13G | AQR Capital Management, LLCinvestment adviser | 10.5M | 5.2% | 2026-06-30 |
| 2026-08-13 | 13G | AQR Capital Management Holdings, LLCparent holding company | 10.5M | 5.2% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 1 | First Eagle Investment Management, LLCinvestment adviser | 851K | 0.4% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 15 | BlackRock, Inc.parent holding company | 25.3M | 12.6% | 2026-06-30 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 10.7M | 5.4% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 10.5M | 5.3% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 18 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G | Lazard Asset Management LLCinvestment adviser | 8.7M | 4.4% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 2 | T. Rowe Price Associates, Inc.investment adviser | 197K | 0.1% | 2025-09-30 |
13F holders
Tracked managers holding XRAY at their latest 13F. JSON8 of the 30 tracked managers held XRAY at their latest 13F, $167.1M in total at quarter-end prices. AQR Capital Management is the largest at $110.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 10.5M | $110.2M | 0.04% | +6.5M |
| D. E. Shaw & Co. | 2026-06-30 | 3.0M | $31.7M | 0.02% | +554K |
| Millennium Management | 2026-06-30 | 857K | $9.1M | 0.00% | +273K |
| Citadel Advisors | 2026-06-30 | 762K | $8.1M | 0.00% | -631K |
| Bridgewater Associates | 2026-06-30 | 370K | $3.9M | 0.02% | new |
| ARK Investment Management | 2026-06-30 | 236K | $2.5M | 0.02% | -31K |
| Two Sigma Investments | 2026-06-30 | 122K | $1.3M | 0.00% | +22K |
| Renaissance Technologies | 2026-06-30 | 33K | $355K | 0.00% | -1.5M |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Dentsply Sirona reported revenue of $898.0M, down 4.1% from the same quarter a year earlier, and net income of $37.0M (0.18 diluted EPS). In FY 2025 it generated $235.0M of operating cash flow and spent $128.0M on dividends. As of 2026-06-30, cash was $239.0M against $2.22B of debt.
- Cash
- $239.0M
- Debt
- $2.22B
- Equity
- $1.35B
- Total assets
- $5.20B
- Shares outstanding
- 199,353,876
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $898.0M | $37.0M | 4.1% | 0.18 |
| Q1 FY 2026 | 2026-03-31 | $880.0M | -$10.0M | -1.1% | -0.05 |
| Q4 FY 2025derived | 2025-12-31 | $961.0M | -$146.0M | -15.2% | n/a |
| Q3 FY 2025 | 2025-09-30 | $904.0M | -$427.0M | -47.2% | -2.14 |
| Q2 FY 2025 | 2025-06-30 | $936.0M | -$45.0M | -4.8% | -0.22 |
| Q1 FY 2025 | 2025-03-31 | $879.0M | $20.0M | 2.3% | 0.10 |
| Q4 FY 2024derived | 2024-12-31 | $905.0M | -$430.0M | -47.5% | n/a |
| Q3 FY 2024 | 2024-09-30 | $951.0M | -$494.0M | -51.9% | -2.46 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $3.68B | -$598.0M | $235.0M | $131.0M | $0 | $128.0M |
| FY 2024 | 2024-12-31 | $3.79B | -$910.0M | $461.0M | $180.0M | $250.0M | $126.0M |
| FY 2023 | 2023-12-31 | $3.96B | -$132.0M | $377.0M | $149.0M | $300.0M | $116.0M |
| FY 2022 | 2022-12-31 | $3.92B | -$950.0M | $517.0M | $149.0M | $150.0M | $104.0M |
| FY 2021 | 2021-12-31 | $4.23B | $411.0M | $657.0M | $142.0M | $200.0M | $92.0M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-24 from the cover page.
What this page is
Dentsply Sirona in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Dentsply Sirona (XRAY), SEC CIK 818479, listed on Nasdaq, classified by the SEC as dental equipment & supplies. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-21.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2025-12-11.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-07.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-10.JSON and CSV
- Company record
- EDGAR filing index for CIK 818479Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as dental equipment & supplies
Other company pages
- MLMMartin Marietta Materials
- MMM3M
- MNSTMonster Beverage
- MOAltria Group
- MODModine Manufacturing
- MOSMosaic
- MPMP Materials
- MPCMarathon Petroleum
- MPWRMonolithic Power Systems
- MRKMerck
- MRNAModerna
- MRSHMarsh & McLennan Companies
- MRVLMarvell Technology
- MSMorgan Stanley
- MSCIMSCI
- MSFTMicrosoft
- MSIMotorola Solutions
- MSTRStrategy
- MTBM&T Bank
- MTCHMatch Group
- MTDMettler-Toledo International
- MTNVail Resorts
Datasets
Frequently Asked Questions
How much of XRAY is sold short?
25,531,560 shares were held short at the 2026-09-30 settlement, 4.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is XRAY's daily short volume?
On 2026-10-23, 787,536 of the 1,400,645 XRAY shares reported to FINRA were sold short, 56.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does XRAY have fails to deliver?
The SEC's latest file shows 3,388 XRAY shares failed to deliver at settlement 2026-09-21. Fails are reported per settlement date and published twice a month with a lag.
Are XRAY insiders buying or selling?
No open-market insider trades were reported for XRAY in the last 90 days. The most recent filings are listed below. Latest filing: Fortson John C. (EVP & CFO) on 2026-08-10.
Have XRAY insiders filed to sell?
1 Form 144 notice on file for XRAY worth $912K at the prices reported; 0 in the last 90 days worth $0. Latest: LUCIER GREGORY T filed on 2025-12-11 to sell 82,200 shares ($912K) from 2025-12-08.
Who owns 5% or more of XRAY?
5 holders report 5% or more of XRAY in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 12.6% of the class (25,295,015 shares), filed 2026-07-08 for an event on 2026-06-30.
What did XRAY report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Dentsply Sirona reported revenue of $898.0M, down 4.1% from the same quarter a year earlier, and net income of $37.0M (0.18 diluted EPS). In FY 2025 it generated $235.0M of operating cash flow and spent $128.0M on dividends. As of 2026-06-30, cash was $239.0M against $2.22B of debt.
Which tracked 13F managers own XRAY?
8 of the 30 tracked 13F managers held XRAY shares at their latest filing, $167.1M in all. The largest: Cliff Asness's AQR Capital Management (10.5M shares, $110.2M), D. E. Shaw & Co. (3.0M shares, $31.7M), Izzy Englander's Millennium Management (857K shares, $9.1M), Ken Griffin's Citadel Advisors (762K shares, $8.1M), Ray Dalio's Bridgewater Associates (370K shares, $3.9M), Cathie Wood's ARK Investment Management (236K shares, $2.5M). The table above lists all 8.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.